It will be interesting to see how they deliver the IL12 since in the past it's been very toxic, and combined with Keytruda's side adverse effects who knows what'll happen. That is a benefit to electroporation which allows a much smaller amount of IL12.
On the other side of the coin it may be that the NCI is well aware of OncoSec's work with EP IL12 & Keytruda which gives some credibility to the things we're doing.
News 
Market Data 
Discover 
